Attention: Data Proxy will be migrated from SWIFT to S3 storage at Friday, the 9th of May 2025 starting from 9pm CEST (my timezone). For more details, please join the rocket chat channel https://chat.ebrains.eu/channel/data-proxy-user-group


Changes for page Neurodiagnoses

Last modified by manuelmenendez on 2025/03/03 22:46

From version 7.1
edited by manuelmenendez
on 2025/01/27 23:21
Change comment: There is no comment for this version
To version 10.1
edited by manuelmenendez
on 2025/01/27 23:52
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -15,7 +15,7 @@
15 15  (((
16 16  = What is this about and what can I find here? =
17 17  
18 -==== **Overview** ====
18 +== **Overview** ==
19 19  
20 20  The //Tridimensional Diagnostic Framework// redefines how neurodegenerative diseases (NDDs) are classified by focusing on:
21 21  
... ... @@ -29,7 +29,7 @@
29 29  * Integration of incomplete datasets using AI-driven probabilistic modeling.
30 30  * Stratification of patients for personalized treatment.
31 31  
32 -==== **Diagnostic Axes** ====
32 +== **Diagnostic Axes** ==
33 33  
34 34  * (((
35 35  **Axis 1: Etiology**
... ... @@ -53,28 +53,11 @@
53 53  * //Tests//: MRI volumetrics, FDG-PET, neuropsychological evaluations.
54 54  )))
55 55  
56 -==== **Case Studies** ====
56 +== **Applications** ==
57 57  
58 -1. (((
59 -**Sporadic Alzheimer’s Disease**:
60 -
61 -* Axis 1: Sporadic (ApoE4, poor sleep habits).
62 -* Axis 2: Amyloid-beta plaques, elevated NFL.
63 -* Axis 3: Right hippocampus atrophy (visual memory loss).
64 -)))
65 -1. (((
66 -**Genetic Parkinson’s Disease**:
67 -
68 -* Axis 1: Genetic (LRRK2 mutation).
69 -* Axis 2: Alpha-synuclein aggregation.
70 -* Axis 3: Substantia nigra degeneration (motor dysfunction).
71 -)))
72 -
73 -==== **Applications** ====
74 -
75 75  This system enhances:
76 76  
77 -* **Research**: By stratifying patients, it reduces cohort heterogeneity in clinical trials.
60 +* **Research**: By stratifying patients, reduces cohort heterogeneity in clinical trials.
78 78  * **Clinical Practice**: Provides dynamic diagnostic annotations with timestamps for longitudinal tracking.
79 79  
80 80  == Who has access? ==
... ... @@ -81,13 +81,13 @@
81 81  
82 82  We welcome contributions from the global community. Let’s build the future of neurological diagnostics together!
83 83  
84 -== How to Contribute: ==
67 +== How to Contribute ==
85 85  
86 86  * Access the `/docs` folder for guidelines.
87 87  * Use `/code` for the latest AI pipelines.
88 88  * Share feedback and ideas in the wiki discussion pages.
89 89  
90 -== Key Objectives: ==
73 +== Key Objectives ==
91 91  
92 92  * Develop interpretable AI models for diagnosis and progression tracking.
93 93  * Integrate data from Human Phenotype Ontology (HPO), Gene Ontology (GO), and other biomedical resources.
... ... @@ -101,7 +101,7 @@
101 101  {{toc/}}
102 102  {{/box}}
103 103  
104 -== Main contents: ==
87 +== Main contents ==
105 105  
106 106  * `/docs`: Documentation and contribution guidelines.
107 107  * `/code`: Machine learning pipelines and scripts.